CB

CDIB BioScience Ventures

North America, California, United States, San Diego

Description

CDIB BioScience Venture Management (CBVM) is a life science venture management company with operations in US and Taiwan.

Investor Profile

CDIB BioScience Ventures has made 18 investments, with 0 in the past 12 months and 11% as lead.

Stage Focus

  • Series C (28%)
  • Series B (22%)
  • Series Unknown (17%)
  • Series A (17%)
  • Series D (11%)
  • Series E (6%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Medical
  • Health Care
  • Biopharma
  • Electronics
  • Manufacturing
  • Therapeutics
  • Communications Infrastructure
  • Advanced Materials
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CDIB BioScience Ventures frequently co-invest with?

Domain Associates
North America, California, United States, San Diego
Co-Investments: 4
Alexandria Real Estate Equities
North America, California, United States, Pasadena
Co-Investments: 2
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 3
180 Degree Capital
North America, New Jersey, United States, Montclair
Co-Investments: 2
Montreux Equity Partners
North America, California, United States, San Francisco
Co-Investments: 3
Oxford Bioscience Partners
North America, Massachusetts, United States, Boston
Co-Investments: 2
Prospect Venture Partners
North America, California, United States, Palo Alto
Co-Investments: 3
Lux Capital
North America, New York, United States, New York
Co-Investments: 2
Venrock
North America, California, United States, Palo Alto
Co-Investments: 4
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 3

What are some of recent deals done by CDIB BioScience Ventures?

ConforMIS

Burlington, Massachusetts, United States

ConforMIS develops personalized, patient-specific implants, and instrumentation for knee-related therapeutics.

Health CareMedical DeviceTherapeutics
Series DJul 9, 2008
Amount Raised: $14,915,000
Ocera Therapeutics

Palo Alto, California, United States

Ocera Therapeutics is a biopharmaceutical company developing novel therapeutics for patients with acute and chronic liver diseases.

BiopharmaBiotechnologyTherapeutics
Series CFeb 20, 2008
Amount Raised: $35,500,000
Epiphany

San Francisco, California, United States

Epiphany Biosciences develops therapeutic products and diagnostic technologies that can prevent or cure the spread of pathogenic viruses.

BiotechnologyHealth DiagnosticsTherapeutics
Series AMar 16, 2007
Amount Raised: $36,000,000
Proprius Pharmaceuticals

San Diego, California, United States

Proprius Pharmaceuticals is a San Diego-based drug developer focused on rheumatology and autoimmune diseases.

BiotechnologyMedicalPharmaceutical
Series AJan 8, 2007
Amount Raised: $11,000,000
Aprima Medical Software

Carrollton, Texas, United States

Aprima Medical Software offers a fully integrated, single application, single database EHR/practice management solution.

Health CareMedicalMedical DeviceSoftware
Series CDec 28, 2006
Amount Raised: $6,800,000
Xanthus Pharmaceuticals

Cambridge, Massachusetts, United States

Xanthus is a biopharmaceutical company.

BiopharmaBiotechnologyMedicalPharmaceutical
Series BDec 1, 2006
Amount Raised: $25,000,000
Elixir Pharmaceuticals

Cambridge, Massachusetts, United States

Elixir Pharmaceuticals develops and commercializes pharmaceuticals for the treatment of metabolic diseases.

BiotechnologyDiabetesPharmaceutical
Series CNov 27, 2006
Amount Raised: $31,000,000
Nanosys

Milpitas, California, United States

Nanosys specializes in the development of quantum dot technology for displays.

Advanced MaterialsComputerConsumer ElectronicsElectronicsManufacturingNanotechnology
Series CNov 9, 2005
Amount Raised: $41,500,000
Cerexa Inc.

New York, New York, United States

Cerexa is a biopharmaceutical company produces a portfolio of anti-infective therapies for the treatment of life-threatening infections.

BiotechnologyHealth CareMedicalPharmaceutical
Series AAug 23, 2005
Amount Raised: $50,000,000
Somaxon Pharmaceuticals

Solana Beach, California, United States

Somaxon Pharmaceuticals is a growing specialty pharmaceutical company dedicated to commercializing proprietary branded prescription

BiotechnologyHealth CarePharmaceutical
Series CJun 6, 2005
Amount Raised: $65,000,000